HomeDBVT • NASDAQ
add
DBV Technologies SA - ADR
Nakaraang pagsara
$9.82
Sakop ng araw
$9.72 - $10.16
Sakop ng taon
$2.20 - $12.78
Market cap
276.88M USD
Average na Volume
28.00K
P/E ratio
-
Dividend yield
-
Mga balita tungkol sa merkado
CNBC
3 oras ang nakalipas
Stock futures tick higher following back-to-back winning weeks: Live updates
0.75%
Investor's Business Daily
4 oras ang nakalipas
Futures Rise With Powell Ahead; 3 Stocks Eye Buy Points
1.23%
3.53%
1.50%
0.078%
Mga Financial
Income Statement
Kita
Net na kita
| (USD) | Hun 2025info | Y/Y na pagbabago |
|---|---|---|
Kita | 1.46M | 26.18% |
Gastos sa pagpapatakbo | 42.58M | 21.63% |
Net na kita | -41.88M | -26.45% |
Net profit margin | -2.86K | -0.21% |
Kita sa bawat share | -0.27 | 82.92% |
EBITDA | -40.35M | -19.42% |
Aktuwal na % ng binabayarang buwis | -0.28% | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (USD) | Hun 2025info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 103.21M | 55.87% |
Kabuuang asset | 143.43M | 25.61% |
Kabuuang sagutin | 57.20M | 63.00% |
Kabuuang equity | 86.22M | — |
Natitirang share | 136.76M | — |
Presyo para makapag-book | 15.59 | — |
Return on assets | -105.96% | — |
Return on capital | -197.60% | — |
Cash Flow
Net change in cash
| (USD) | Hun 2025info | Y/Y na pagbabago |
|---|---|---|
Net na kita | -41.88M | -26.45% |
Cash mula sa mga operasyon | -33.90M | 3.33% |
Cash mula sa pag-invest | -38.00K | -105.50% |
Cash mula sa financing | 116.95M | 354,484.85% |
Net change in cash | 90.25M | 355.57% |
Malayang cash flow | -17.22M | 35.69% |
Tungkol
DBV Technologies SA is a publicly owned French biopharmaceutical firm headquartered in Bagneux, France. DBV Technologies is known for developing "Viaskin" technology for administering allergens or antigens to intact skin while avoiding any transfer to the blood. Viaskin Peanut clinical development has received Fast Track designation from the US Food and Drug Administration. Wikipedia
Itinatag
Mar 29, 2002
Website
Mga Empleyado
109
